Dr Lieberman offers perspective on the healthcare landscape in America, repeal of the Affordable Care Act, and fiscal implications associated with clinical research and NIH funding.

Dr Peter Yellowlees discusses a recent publication reviewing multiple studies on the use of droperidol for psychosis-induced aggression or agitation.

Dr Peter Yellowlees talks about parent-mediated social communication therapy for young children with autism.

Dr Peter Yellowlees talks about sponsorship bias in the comparative efficacy of psychotherapy and pharmacotherapy for adult depression.

Dr Peter Yellowlees talks about clozapine vs first- and second-generation antipsychotics in treatment-refractory schizophrenia.

According to Dr Jeffrey Lieberman, history shows a slippery slope away from ethics when psychiatrists, psychologists, and analysts play politics.

Dr Peter Yellowlees discusses the effect of psychotherapy for depression on patients' quality-of-life measures based on a meta-analysis on 44 randomized clinical trials.

Dr Peter Yellowlees discusses results of trial of exposure-based cognitive-behavioral therapy for somatic symptom disorder and illness anxiety disorder.

Dr Ramsey discusses a new RCT that shows how the right diet can enhance and augment other treatments for depression.

Beware of nutrient deficiencies in your vegetarian patients who are considering pregnancy, especially vitamin B12, iron, zinc, and omega-3 fatty acids.